Bridget Wagner

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.

J. Goldin, D. Furst, Y. Shima, 2020, The Lancet. Respiratory medicine.

Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open Label Extension of a Phase 3 Randomized Controlled Trial.

F. Martinez, G. Raghu, J. Goldin, 2021, American journal of respiratory and critical care medicine.

A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy.

C. Macken, D. Richman, D. Scadden, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

A Phase II Randomized Study of HIV-Specific T-Cell GeneTherapy in Subjects with Undetectable Plasma Viremiaon Combination Antiretroviral Therapy

C. Macken, D. Richman, D. Scadden, 2002 .

Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects

C. Macken, D. Richman, D. Scadden, 2003, AIDS.